The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche’s SBX sequencing technology1, with an initial focus on critically ill newborns and their parents.
Whole genome sequencing can help diagnose babies with suspected genetic disorders, such as cystic fibrosis and sickle cell disease.
This project will explore how this technology could become part of routine clinical practice for newborns, as well as its use in other research applications.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.